Carlos Trujillo - Nov 20, 2023 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Chief Financial Officer, Director
Signature
/s/ Carlos A. Trujillo
Stock symbol
PMCB
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/22/2023, 05:01 PM
Previous filing
Sep 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +85K $0.00 85K Nov 20, 2023 Common Stock 85K $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 50% on November 20, 2023 and 50% on November 20, 2024.